Seeking Alpha
0
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

IPO Preview: Nexvet Biopharma Plc

Based in Dublin, Ireland, Nexvet Biopharma plc (NVET) scheduled a $58 million IPO on Nasdaq with a market capitalization of $160 million at a price range midpoint of $14.50 for Thursday, Feb. 5, 2015.

The full IPO calendar is available at IPOpremium

SEC Documents

Manager, Joint-managers: BofA Merrill Lynch, Cowen
Co-managers: Piper Jaffray, JMP Securities

End of lockup (180 days): Tuesday, August 4, 2015
End of 25-day quiet period: Monday, March 2, 2015

Summary
NVET is a clinical stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing novel, species-specific biologics based on human biologics.

As a class, biologics, which include mAbs and fusion proteins, have transformed human medicine in recent decades and represent some of the top-selling therapies on the market today.

Veterinary care is one of the fastest growing industries in the overall U.S. companion animal market and is estimated to reach… Read More …